Cargando…

Imaging Biomarkers in Young Patients With ADPKD

Detalles Bibliográficos
Autores principales:	Yang, Xinyi, Wang, Wei, Gitomer, Berenice, Cadnapaphornchai, Melissa A., Xing, Fuyong, Chonchol, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577310/ https://www.ncbi.nlm.nih.gov/pubmed/37850021 http://dx.doi.org/10.1016/j.ekir.2023.07.004

Ejemplares similares

Characterization of Primary Cilia in Osteoblasts Isolated From Patients With ADPKD and CKD
por: Pereira, Renata C, et al.
Publicado: (2021)

Metabolic profiling in children and young adults with autosomal dominant polycystic kidney disease
por: Baliga, Madhurima M., et al.
Publicado: (2021)

Curcumin therapy to treat vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease: Design and baseline characteristics of participants
por: Nowak, Kristen L., et al.
Publicado: (2020)

The imaging of total kidney volume in ADPKD
por: Cavoli, Gioacchino Li, et al.
Publicado: (2020)

OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD
por: Perrone, Ronald D., et al.
Publicado: (2023)

Affected parent sex and severity of autosomal dominant polycystic kidney disease: a retrospective cohort study
por: Nowak, Kristen L., et al.
Publicado: (2018)

Antenatally Diagnosed ADPKD
por: Aldridge, Melanie, et al.
Publicado: (2018)

Simultaneous laparoscopic nephrectomy in ADPKD
por: Baishya, Ramen Kumar, et al.
Publicado: (2010)

Screening and Management for Intracranial Aneurysms in Japanese Patients With ADPKD
por: Matsuura, Ryo, et al.
Publicado: (2022)

Effect of a Somatostatin Analogue on the Vasopressin Pathway in Patients With ADPKD
por: Messchendorp, A. Lianne, et al.
Publicado: (2019)

Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients
por: Bargagli, Matteo, et al.
Publicado: (2021)

Urinary Biomarkers at Early ADPKD Disease Stage
por: Petzold, Katja, et al.
Publicado: (2015)

Evaluation of advanced imaging biomarkers at kidney failure in patients with ADPKD: a pilot study
por: Wigerinck, Stijn, et al.
Publicado: (2023)

Heterogeneous Cardiovascular Profiles in CKD: ADPKD Versus non-ADPKD
por: Au, Eric H.K., et al.
Publicado: (2022)

Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients
por: Hanudel, Mark R., et al.
Publicado: (2019)

Intrafamilial Variability of ADPKD
por: Lanktree, Matthew B., et al.
Publicado: (2019)

Author’s Reply to Correspondence: “Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients”
por: Heida, Judith E., et al.
Publicado: (2021)

Renal Volume in ADPKD Patient Evaluation
por: Galliani, M., et al.
Publicado: (2020)

Abdominal Imaging in ADPKD: Beyond Total Kidney Volume
por: Caroli, Anna, et al.
Publicado: (2023)

The Impact of COVID-19 on Patients With ADPKD
por: Kutky, Meherzad, et al.
Publicado: (2021)

The Presence of Kidney Cyst Infections in Patients With ADPKD After Kidney Transplantation: Need for Urological Analysis?
por: Geertsema, Paul, et al.
Publicado: (2022)

Exome sequencing of Saudi Arabian patients with ADPKD
por: Al-Muhanna, Fahad A., et al.
Publicado: (2019)

Acute Kidney Injury in ADPKD Patients with Pneumonia
por: Franco Palacios, Carlos, et al.
Publicado: (2011)

Defining Cardiac Dysfunction in ADPKD
por: Kuo, Ivana Y.
Publicado: (2023)

Cardiovascular Manifestations and Management in ADPKD
por: Sagar, Priyanka S., et al.
Publicado: (2023)

Polycystins, ADPKD, and Cardiovascular Disease
por: Kuo, Ivana Y., et al.
Publicado: (2019)

Hypertension in young adults with autosomal dominant polycystic kidney disease: a case for early screening?
por: Cadnapaphornchai, Melissa A, et al.
Publicado: (2023)

In Reply to “The Presence of Kidney Cyst Infections in ADPKD Patients After Kidney Transplantation: Need for Urological Analysis?"
por: Ronsin, Charles, et al.
Publicado: (2022)

The Effect of Enlarged Kidneys on Calculated Body Mass Index Categorization in Transplant Recipients With ADPKD
por: Freise, Jonathan, et al.
Publicado: (2019)

Biological Efficacy and Safety of Niacinamide in Patients With ADPKD
por: El Ters, Mireille, et al.
Publicado: (2020)

A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model
por: McEwan, Phil, et al.
Publicado: (2018)

The BC ADPKD Network: A Comprehensive Provincial Approach to Support Specialized and Locally Delivered Multidisciplinary ADPKD Care
por: Bevilacqua, M., et al.
Publicado: (2021)

PKD1 Compared With PKD2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies
por: Steele, Cortney, et al.
Publicado: (2021)

Tolvaptan in ADPKD Patients With Very Low Kidney Function
por: Torres, Vicente E., et al.
Publicado: (2021)

The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression
por: Nguyen, Dustin T., et al.
Publicado: (2023)

The importance of quantifying genetic heterogeneity in ADPKD
por: Chapman, Arlene B.
Publicado: (2014)

Renal Transcatheter Arterial Embolization for ADPKD
por: Oda, Yasuhiro, et al.
Publicado: (2020)

Germline Mutations for Kidney Volume in ADPKD
por: Kataoka, Hiroshi, et al.
Publicado: (2021)

MR Brain Screening in ADPKD Patients: To Screen or not to Screen?
por: Capelli, I., et al.
Publicado: (2021)

Case report: tolvaptan-associated creatine kinase elevation in two patients with autosomal dominant polycystic kidney disease (ADPKD)
por: Agraz-Pamplona, I., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vmr1b0esa1je8mbrg14gn7k83h